Welcome to the June edition of our newsletter! Bringing you our latest discoveries in high-throughput screening, genomic and cellular analysis, colony selection, and microplate detection. Visit us at: moleculardevices.com
Essential lab and manufacturing processes for successful drug discovery, development, and production
In this podcast, Tim Bolus, Compliance Program Manager at Molecular Devices, provides a 15-minute in-depth exploration of the regulatory landscape of drug discovery and development. He examines the good lab and manufacturing processes essential to successful drug discovery, development, and production.
Hear Tim’s insight and discover how to best prepare your lab to pass FDA and EudraLex regulations and hear some firsthand cautionary tales, all in this information-packed podcast.
Introduction to GxP
Why is GLP important in drug development?
Why is GMP important in the manufacturing processes late down the line?
Organoids are becoming invaluable in disease modeling and drug screening as they more closely mimic the in vivo environment compared to their 2D counterparts. And with applications expected to grow over the next few years, organoids will form the foundation of innovations yet to come in precision, translational, and regenerative medicine. Is your lab prepared?
This eBook delves into the history, current role, and future impact of organoids in drug discovery and how you can successfully integrate them into your research. Topics include:
Organoid research workflow examples
Optimal technology for accurate, efficient research
Example research applications: brain, intestinal, and patient-derived organoids
We are pleased to announce our commercial partnership with Core Life Analytics’ data analytics platform, Automating labor-intensive plate-based assays increases walkaway time, throughput, and reproducibility by reducing the amount of common, repetitive, hands-on steps for researchers. Our new ready-made workcells for Enzyme-linked immunosorbent assay (ELISA) workflows offer automation capabilities ranging from entry level to advanced.
The ELISA workcells offer five levels of automation, taking the hands-on work out of plate loading and advancing until manual intervention is almost entirely unnecessary. With this approach, we’re leveraging our extensive experience automating workflows to best support scientists wherever they are in their automation journey.
Benefits of automating your synthetic biology workflow
Join our resident SynBio specialist, Dwayne E. Carter, PhD, as he walks us through the benefits of automating your synthetic biology workflow on our latest blog post, Synthetic Biology Automation: Five Tips to Improve Your Molecular Cloning Process.
From manual picking to automated picking using a high-throughput colony picker
Integrating lab devices for a fully automated molecular cloning workflow
Join our guest bloggers Dr Carter Mitchell, Chief Science Officer, and Dr Sharath Madasu, Manager of Protein Characterization at Kemp Proteins, as they explore the role of monoclonal antibodies (mAbs) against SARS-CoV-2.
Dive into the ways in which mAb development workflows have recently evolved in response to emerging SARS-CoV-2 variants.
Key discussion points:
How the pandemic has advanced and accelerated the development of mAbs
Where the biggest challenges and bottlenecks lie for mAb development
How to accelerate mAb discovery and development and the role of automation
What the future of SARS-CoV-2 treatment will look like
Please be advised that this email may contain confidential information. If you are not the intended recipient, please notify us by email by replying to the sender and delete this message. The sender disclaims that the content of this email constitutes an offer to enter into, or the acceptance of, any agreement; provided that the foregoing does not invalidate the binding effect of any digital or other electronic reproduction of a manual signature that is included in any attachment.